Trillium Therapeutics Inc. Strengthens its Board of Directors
11/5/2008 2:34:35 PM
More...
|
Trillium Therapeutics Inc. Strengthens its Board of Directors
11/5/2008 10:35:31 AM
More...
|
Trillium Therapeutics Inc. Raises C$12 Million Third Round
9/18/2008 8:56:12 AM
More...
|
Trillium Therapeutics Inc.'s TTI-1612 Product Receives Orphan Drug Designation In Europe And The United States
12/19/2006 1:20:59 PM
More...
|
Trillium Therapeutics Inc.'s TTI-1612 Product Receives Orphan Drug Designation In Europe And The United States
12/19/2006 10:21:08 AM
More...
|
Trillium Therapeutics Inc. Acquires Arthron Ltd.
10/19/2005 5:13:18 PM
More...
|
Trillium Therapeutics Inc. And Genentech, Inc. (DNA) Enter Into Global License Agreement
10/19/2005 5:12:27 PM
More...
|
Professor Marc Feldmann Joins Trillium Therapeutics Inc.'s Scientific Advisory Board
10/19/2005 5:11:42 PM
More...
|
Trillium Therapeutics Inc. Adds Major Cytokine Receptor Antagonist Program
10/19/2005 5:11:35 PM
More...
|
Trillium Therapeutics Inc. Welcomes Dr. Michael Moore To Board Of Directors
10/19/2005 5:10:06 PM
More...
|
|